Alkermes (ALKS) Deferred Taxes (2011 - 2026)
Alkermes' (ALKS) quarterly Deferred Taxes came in at -$8.8 million in Q1 2026, down 450.5% year-on-year from $2.5 million in Q1 2025, and down 127.99% on a QoQ basis from $31.4 million in Q3 2025.
Alkermes (ALKS) Deferred Taxes (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Deferred Taxes data on file, last reported at -$8.8 million in Q1 2026.
- On a quarterly basis, Deferred Taxes fell 450.5% year-over-year to -$8.8 million in Q1 2026; TTM through Mar 2026 was $21.7 million, a 38.88% decrease from a year earlier, with the FY2024 full-year figure at $40.5 million, up 140.56% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$8.8 million, down from $31.4 million in the prior quarter.
- Over the last five years, Deferred Taxes for ALKS reached as high as $31.4 million in Q3 2025 and fell as low as -$52.5 million in Q4 2023.
- Historically, Deferred Taxes has averaged -$4.4 million across 5 years, with a median of -$2.7 million in 2023.
- Across the five-year window, Deferred Taxes sank 657.58% in 2022 and surged 803.42% in 2024, its largest moves.
- Year by year, Deferred Taxes stood at $21.3 million in 2022, then sank by 346.81% to -$52.5 million in 2023, then soared by 115.63% to $8.2 million in 2024, then jumped by 282.43% to $31.4 million in 2025, then sank by 127.99% to -$8.8 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$8.8 million in Q1 2026, $31.4 million in Q3 2025, and -$3.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -8.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.79 Mn |
| Sep 30, 2025 | 31.39 Mn |
| Jun 30, 2025 | -3.41 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 8.21 Mn |
| Sep 30, 2024 | 10.59 Mn |
| Jun 30, 2024 | 14.21 Mn |
| Mar 31, 2024 | 7.52 Mn |
| Dec 31, 2023 | -52.52 Mn |
| Sep 30, 2023 | -9.25 Mn |
| Jun 30, 2023 | -2.02 Mn |
| Mar 31, 2023 | -36.12 Mn |
| Dec 31, 2022 | 21.28 Mn |
| Sep 30, 2022 | -13.26 Mn |
| Jun 30, 2022 | -11.51 Mn |
| Mar 31, 2022 | -29.30 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | -8.79 Mn |
| Jun 30, 2021 | 5.55 Mn |
| Mar 31, 2021 | 5.26 Mn |